Research advances in congenital non-hemolytic jaundice

Jie LU; Wu LI; Ye LIU

doi:10.3969/j.issn.1001-5256.2021.01.048

Volume 37 Issue 1

Jan. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(1): 216-220

PDF( 2049 KB)

Research advances in congenital non-hemolytic jaundice

DOI: 10.3969/j.issn.1001-5256.2021.01.048

Department of Infectious Diseases, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China

Received Date: 2020-06-27
Accepted Date: 2020-08-31
Published Date: 2021-01-20

Abstract

Abstract

Congenital non-hemolytic jaundice is an important type of jaundice diseases, and except breast milk jaundice, the other types of this disease are relatively rare in clinical practice. Most of them belong to genetic and metabolic liver diseases, including Gilbert syndrome, Crigler-Najjar syndrome, and Lucey-Driscoll syndrome with an increase in unconjugated bilirubin and Dubin-Johnson syndrome and Rotor syndrome with an increase in conjugated bilirubin. With reference to the recent literature in China and foreign countries, this article reviews the pathogenesis, genetic characteristics, diagnosis, treatment, and differential diagnosis of six types of hereditary congenital unconjugated jaundice.
- Jaundice,
- Gilbert Disease,
- Crigler-Najjar Syndrome,
- Jaundice, Chronic Idiopathic

FullText(HTML)

References(40)

References

[1]	BOSMA PJ, CHOWDHURY JR, BAKKER C, et al. The genetic basis of the reduced expression of bilirubin udp-glucuronosyltransferase 1 in gilbert's syndrome[J]. N Engl J Med, 1995, 333(18): 1171-1175. DOI: 10.1056/NEJM199511023331802
[2]	WAGNER KH, SHIELS RG, LANG CA, et al. Diagnostic criteria and contributors to gilbert's syndrome[J]. Crit Rev Clin Lab Sci, 2018, 55(2): 129-139. DOI: 10.1080/10408363.2018.1428526
[3]	BLACK M, BILLING BH. Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome[J]. N Engl J Med, 1969, 280(23): 1266-1271. DOI: 10.1056/NEJM196906052802303
[4]	MARUO Y, NAKAHARA S, YANAGI T, et al. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type Ⅱ and gilbert syndrome[J]. J Gastroenterol Hepatol, 2016, 31(2): 403-408. DOI: 10.1111/jgh.13071
[5]	ARIAS IM, GARTNER LM, COHEN M, et al. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity[J]. Am J Med, 1969, 47(3): 395-409. DOI: 10.1016/0002-9343(69)90224-1
[6]	KUI LY, WANG MY, ZHOU BI, et al. Study on UGT1A1 gene polymorphism in infantile hyperbilirubinemia of different nationalities in Yunnan Province[J]. J Mol Diagn Ther, 2020, 12(3): 386-390. (in Chinese) DOI: 10.3969/j.issn.1674-6929.2020.03.030 奎莉越, 王明英, 周百灵, 等. 云南省婴儿期不同民族高非结合性胆红素血症UGT1A1基因多态性研究[J]. 分子诊断与治疗杂志, 2020, 12(3): 386-390. DOI: 10.3969/j.issn.1674-6929.2020.03.030
[7]	MATSUI K, MARUO Y, SATO H, et al. Combined effect of regulatory polymorphisms on transcription of UGT1A1 as a cause of gilbert syndrome[J]. BMC Gastroenterol, 2010, 10: 57. DOI: 10.1186/1471-230X-10-57
[8]	BOSMA PJ, CHOWDHURY JR, BAKKER C, et al. The genetic basis of the reduced expression of bilirubin udp-glucuronosyltransferase 1 in gilbert's syndrome[J]. N Engl J Med, 1995, 333(18): 1171-1175. DOI: 10.1056/NEJM199511023331802
[9]	THOGULUVA CV, JOHN S. Gilbert syndrome[M]. Treasure Island (FL): StatPearls Publishing, 2020.
[10]	LI LF, DENG GH, MAO Q. Linkage relationship of UGT1A1 pathogenic variation in Gilbert syndrome[J]. Third Mil Med Univ, 2020, 42(2): 168-175. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX202002011.htm 李露锋, 邓国宏, 毛青. Gilbert综合征UGT1A1致病变异的连锁关系研究[J]. 第三军医大学学报, 2020, 42(2): 168-175. https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX202002011.htm
[11]	BORUCKI K, WEIKERT C, FISHER E, et al. Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy german volunteers[J]. Clin Biochem, 2009, 42(16-17): 1635-1641. DOI: 10.1016/j.clinbiochem.2009.08.011
[12]	YAMAMOTO K, SATO H, FUJIYAMA Y, et al. Contribution of two missense mutations (g71r and y486d) of the bilirubin udp glycosyltransferase (UGT1A1) gene to phenotypes of gilbert's syndrome and crigler-najjar syndrome type Ⅱ[J]. Biochim Biophys Acta, 1998, 1406(3): 267-273. DOI: 10.1016/S0925-4439(98)00013-1
[13]	ERLINGER S, ARIAS IM, DHUMEAUX D. Inherited disorders of bilirubin transport and conjugation: New insights into molecular mechanisms and consequences[J]. Gastroenterology, 2014, 146(7): 1625-1638. DOI: 10.1053/j.gastro.2014.03.047
[14]	LIANG C, LUO L, BAI J, et al. Analysis of mutations in uridine diphosphate glucuronosyltransferase A1 gene associated with Gilbert syndrome and Crigler-Najjar syndrome[J]. Chin J Hepatol, 2020, 28(5): 428-433. (in Chinese) DOI: 10.3760/cma.j.cn501113-20200217-00051 梁晨, 罗磊, 白洁, 等. Gilbert综合征和Crigler-Najjar综合征相关尿苷二磷酸葡糖醛酸转移酶A1基因突变位点特征分析[J]. 中华肝脏病杂志, 2020, 28(5): 428-433. DOI: 10.3760/cma.j.cn501113-20200217-00051
[15]	KANG LL, MA YJ, ZHANG HD. Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome[J]. Medicine (Baltimore), 2020, 99(7): e19109. DOI: 10.1097/MD.0000000000019109
[16]	ZHANG M. Analysis of the diagnostic value of UGT1A1 gene detection in Gilbert syndrome[D]. Wuhan: Huazhong University of Science and Technology, 2019. (in Chinese) 张梦. UGT1A1基因检测在Gilbert综合征中的诊断价值分析[D]. 武汉: 华中科技大学, 2019.
[17]	VITEK L, BELLAROSA C, TIRIBELLI C. Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?[J]. Clin Pharmacol Ther, 2019, 106(3): 568-575. DOI: 10.1002/cpt.1341
[18]	FATA CR, GILLIS LA, PACHECO MC. Liver fibrosis associated with crigler-najjar syndrome in a compound heterozygote: A case report[J]. Pediatr Dev Pathol, 2017, 20(6): 522-525. DOI: 10.1177/1093526617697059
[19]	RAZEK A, TAMAN SE, EL REGAL ME, et al. Diffusion tensor imaging of microstructural changes in the gray and white matter in patients with crigler-najjar syndrome type I[J]. J Comput Assist Tomogr, 2020, 44(3): 393-398. DOI: 10.1097/RCT.0000000000001008
[20]	APGAR JF, TANG JP, SINGH P, et al. Corrigendum: Quantitative systems pharmacology model of hugt1a1-modrna encoding for the ugt1a1 enzyme to treat crigler-najjar syndrome type 1[J]. CPT Pharmacometrics Syst Pharmacol, 2020, 9(3): 185. DOI: 10.1002/psp4.12484
[21]	MEMON N, WEINBERGER BI, HEGYI T, et al. Inherited disorders of bilirubin clearance[J]. Pediatr Res, 2016, 79(3): 378-386. DOI: 10.1038/pr.2015.247
[22]	ARIAS IM, WOLFSON S, LUCEY JF, et al. Transient familial neonatal hyperbilirubinemia[J]. J Clin Invest, 1965, 44: 1442-1450. DOI: 10.1172/JCI105250
[23]	BEVAN BR, HOLTON JB. Inhibition of bilirubin conjugation in rat liver slices by free fatty acids, with relevance to the problem of breast milk jaundice[J]. Clin Chim Acta, 1972, 41: 101-107. DOI: 10.1016/0009-8981(72)90501-3
[24]	PRAMEELA KK. Breastfeeding during breast milk jaundice - a pathophysiological perspective[J]. Med J Malaysia, 2019, 74(6): 527-533. http://www.researchgate.net/publication/338582429_Breastfeeding_during_breast_milk_jaundice_-_a_pathophysiological_perspective
[25]	BRATTON S, CANTU RM, STERN M. Breast milk jaundice[M]. Treasure Island (FL): StatPearls Publishing, 2020.
[26]	TOH S, WADA M, UCHIUMI T, et al. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the atp-binding-cassette region in dubin-johnson syndrome[J]. Am J Hum Genet, 1999, 64(3): 739-746. DOI: 10.1086/302292
[27]	MEMON N, WEINBERGER BI, HEGYI T, et al. Inherited disorders of bilirubin clearance[J]. Pediatr Res, 2016, 79(3): 378-386. DOI: 10.1038/pr.2015.247
[28]	WU L, LI Y, SONG Y, et al. A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China[J]. Orphanet J Rare Dis, 2020, 15(1): 74. DOI: 10.1186/s13023-020-1346-4
[29]	van de STEEG E, STRÁNECKY V, HARTMANNOVÁ H, et al. Complete OATP1B1 and OATP1B3 deficiency causes human rotor syndrome by interrupting conjugated bilirubin reuptake into the liver[J]. J Clin Invest, 2012, 122(2): 519-528. DOI: 10.1172/JCI59526
[30]	AHMED P, PRATT A, LAND VJ, et al. Multiple plasma exchanges successfully maintain a young adult patient with crigler-najjar syndrome type I[J]. J Clin Apher, 1989, 5(1): 17-20. DOI: 10.1002/jca.2920050107
[31]	CORPECHOT C, BARBU V, CHAZOUILLÈRES O, et al. Genetic contribution of ABCC2 to dubin-johnson syndrome and inherited cholestatic disorders[J]. Liver Int, 2020, 40(1): 163-174. DOI: 10.1111/liv.14260
[32]	MORⅡ K, YAMAMOTO T. Images in clinical medicine. dubin-johnson syndrome[J]. N Engl J Med, 2016, 375(1): e1. DOI: 10.1056/NEJMicm1509529
[33]	BAR-MEIR S, BARON J, SELIGSON U, et al. 99mTC-HIDA cholescintigraphy in dubin-johnson and rotor syndromes[J]. Radiology, 1982, 142(3): 743-746. DOI: 10.1148/radiology.142.3.7063695
[34]	ZHOU D, QI S, ZHANG W, et al. Insertion of line-1 retrotransposon inducing exon inversion causes a rotor syndrome phenotype[J]. Front Genet, 2019, 10: 1399. http://www.ncbi.nlm.nih.gov/pubmed/32082363
[35]	KAGAWA T, OKA A, KOBAYASHI Y, et al. Recessive inheritance of population-specific intronic line-1 insertion causes a rotor syndrome phenotype[J]. Hum Mutat, 2015, 36(3): 327-332. DOI: 10.1002/humu.22745
[36]	DANIELSON ML, SAWADA GA, RAUB TJ, et al. In silico and in vitro assessment of oatp1b1 inhibition in drug discovery[J]. Mol Pharm, 2018, 15(8): 3060-3068. DOI: 10.1021/acs.molpharmaceut.8b00168
[37]	ANSAR S, TRAN K, PINNER J, et al. A rare cause of ductopenia: Adult onset alagille syndrome[J]. Pathology, 2020, 52(5): 610-612. DOI: 10.1016/j.pathol.2020.04.015
[38]	Li XS, SHU SN, HUANG ZH. Progress in diagnosis and treatment of progressive familial intrahepatic cholestasis[J]. Chin J Pract Pediatr, 2020, 35(4): 319-323. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK202004019.htm 李雪松, 舒赛男, 黄志华. 进行性家族性肝内胆汁淤积症诊治进展[J]. 中国实用儿科杂志, 2020, 35(4): 319-323. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK202004019.htm
[39]	HAYASAKA K. Metabolic basis and treatment of citrin deficiency[J]. J Inherit Metab Dis, 2020.[Online ahead of print]. DOI: 10.1002/jimd.12294
[40]	CHEN JY, WU JF, KIMURA A, et al. AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases[J]. Pediatr Neonatol, 2020, 61(1): 75-83. http://www.sciencedirect.com/science/article/pii/S1875957219300956

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (591) PDF downloads(98)

Research advances in congenital non-hemolytic jaundice

DOI: 10.3969/j.issn.1001-5256.2021.01.048

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research advances in congenital non-hemolytic jaundice

DOI: 10.3969/j.issn.1001-5256.2021.01.048

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content